Search results
‘I Tried Out For A Reality Dating Show But Got Ghosted After My Photos Showed My Psoriasis’
Women's Health via Yahoo News· 4 days agoMichelle Lee had an itchy skin rash from plaque psoriasis for months, but doctors mistook it for an...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 20 hours agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
Supplements for Psoriasis: Which Ones Have Benefits or Risks?
Verywell Health via Yahoo News· 6 days agoSupplements that may help improve or manage psoriasis symptoms include oral supplements like vitamin...
Salicylic acid for psoriasis: Benefits, risks, and uses
Medical News Today· 6 days agoSalicylic acid may reduce both the appearance and symptoms of psoriasis. It can exfoliate the skin...
FDA Approves Second Ustekinumab Biosimilar
Medscape· 6 days agoThe biosimilar is expected to be marketed in the United States on or after February 21, 2025.
Novartis shares jump as drugmaker boosts outlook
Market Watch· 59 minutes agoNovartis shares rallied on Tuesday as the Swiss drugmaker raised its outlook for the year after seeing strong demand for heart and psoriasis drugs.
Skin Cancer and Rash: When Do Symptoms Suggest Cancer?
Verywell Health via Yahoo News· 6 days agoIt has a variety of appearances and may mimic psoriasis or eczema, but doesn’t cause a widespread...
What Can Cause a Rash Around the Eyes?
Verywell Health via Yahoo News· 19 hours agoMany conditions can cause a rash around the eyes, from infections to dermatological conditions like dermatitis or psoriasis. Here’s what you need to...
Novartis raises guidance after beating Q1 expectations By Reuters
Investing.com· 4 hours agoFRANKFURT (Reuters) -Swiss drugmaker Novartis (LON:0QLR) raised its full-year guidance on wider use...
Drugmaker Novartis climbs 4.4% after guidance rise on sales of blockbuster drugs
CNBC· 1 hour agoNovartis' net sales rose 11% in the first three months of the year, while core operating income...
